| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/01/2013 | CN101915834B Colloidal gold colloidal gold detection test paper strip of shrimp TSV (Taura Syndrome Virus) |
| 05/01/2013 | CN101892277B Antibacterial peptide preparation method and specific strain thereof |
| 05/01/2013 | CN101820907B Peptide with multiple epitopes |
| 05/01/2013 | CN101730711B Preprocalcitonin antigen T epitopes |
| 05/01/2013 | CN101535340B Erythropoietin compositions |
| 05/01/2013 | CN101395178B Spider silk proteins and methods for producing spider silk proteins |
| 05/01/2013 | CN101384617B Multimeric complexes of antigens and an adjuvant |
| 05/01/2013 | CN101094688B Multimeric constructs |
| 04/30/2013 | US8431803 Maize variety hybrid X03A178 |
| 04/30/2013 | US8431793 Soybean cultivar 11133031 |
| 04/30/2013 | US8431774 Plant-based expression of avian interleukin-12 and methods of producing and using same |
| 04/30/2013 | US8431772 Diacylglycerol acyltransferase sequences and related methods |
| 04/30/2013 | US8431769 Non-aggregating fluorescent proteins and methods for using the same |
| 04/30/2013 | US8431688 Synthetic peptide constructs for the diagnosis and treatment of Periodontitis associated with Porphyromonas gingivalis |
| 04/30/2013 | US8431685 Polymer-based sustained release device |
| 04/30/2013 | US8431538 HDAC inhibitors and therapeutic methods of using same |
| 04/30/2013 | US8431535 Methods for treating local tracheal, bronchial or alveolar bleeding or hemoptysis |
| 04/30/2013 | US8431534 GRF-containing lyophilized pharmaceutical compositions |
| 04/30/2013 | US8431526 Compositions and methods for prion decontamination |
| 04/30/2013 | US8431525 Coelenteramide analogs |
| 04/30/2013 | US8431384 Stable protein storage and stable nucleic acid storage in recoverable form |
| 04/30/2013 | US8431380 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 04/30/2013 | US8431361 Bacterial cells, optimized nucleotide sequences and methods for improved expression of recombinant Clostridium difficile toxin B |
| 04/30/2013 | US8431359 Nucleotide sequences coding tissue factor pathway inhibitor for use in treatment and prevention of blood disorders |
| 04/30/2013 | US8431355 Process for screening glycoform-specific antibodies |
| 04/30/2013 | US8431354 Bacterial pheromones and uses therefor |
| 04/30/2013 | US8431350 Composition and methods for the diagnosis of immune related diseases involving the PRO52254 polypeptide |
| 04/30/2013 | US8431139 Nucleic acids and proteins from Streptococcus groups A and B |
| 04/30/2013 | US8431129 Method of treating fibroproliferative disorders of the heart and lung |
| 04/30/2013 | US8431128 Enterococcus antigens |
| 04/30/2013 | US8431123 Method for treating systemic bacterial, fungal and protozoan infection |
| 04/30/2013 | CA2730627C Human and mouse targeting peptides identified by phage display |
| 04/30/2013 | CA2687542C Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin |
| 04/30/2013 | CA2575388C Methods and compositions for modulating flowering and maturity in plants |
| 04/30/2013 | CA2558621C Promoter from maize prolamin seed storage protein and uses thereof |
| 04/30/2013 | CA2557174C Albumin-purification method comprising a nanofiltration step, solution, and composition for therapeutic use containing same |
| 04/30/2013 | CA2503125C Novel composition and methods for the treatment of immune related diseases |
| 04/30/2013 | CA2475235C Production process of recombinant placental growth factor |
| 04/30/2013 | CA2458995C Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof |
| 04/30/2013 | CA2453522C Antigen presenting cells, method for their preparation and their use for cancer vaccines |
| 04/30/2013 | CA2435664C Ncc2705-the genome of a bifidobacterium |
| 04/30/2013 | CA2412612C Eg-vegf nucleic acids and polypeptides and methods of use |
| 04/30/2013 | CA2403964C Compositions and methods for dendritic cell-based immunotherapy |
| 04/30/2013 | CA2383154C Baff receptor (bcma), an immunoregulatory agent |
| 04/30/2013 | CA2365742C Formulations for amylin agonist peptides |
| 04/25/2013 | WO2013059593A1 Anti-cd22 chimeric antigen receptors |
| 04/25/2013 | WO2013059525A1 Peptidomimetic macrocyles |
| 04/25/2013 | WO2013059493A1 Dengue virus e-glycoprotein polypeptides containing mutations that eliminate immunodominant cross-reactive epitopes |
| 04/25/2013 | WO2013059405A1 Etanercept formulations stabilized with amino acids |
| 04/25/2013 | WO2013059336A1 Amylin-calcitonin chimeric peptides conjugated to duration enchancing moieties |
| 04/25/2013 | WO2013059213A1 Chemically and thermodynamically stable insulin analogues and improved methods for their production |
| 04/25/2013 | WO2013058762A1 Separation of acetylated proteins from unacetylated proteins |
| 04/25/2013 | WO2013058485A1 Methods for purifying erythropoietin analogs having lower isoelectric point |
| 04/25/2013 | WO2013058404A1 Design method for rna-binding protein using ppr motif, and use thereof |
| 04/25/2013 | WO2013057705A1 Plants having enchanced yield-related traits and method for making the same |
| 04/25/2013 | WO2013057681A1 Drought-tolerant transgenic plants comprising decreased myc4 activity and methods for their use |
| 04/25/2013 | WO2013057599A1 Biomarker |
| 04/25/2013 | WO2013057586A1 Compositions and methods for producing soluble t - cell receptors |
| 04/25/2013 | WO2013057513A2 Therapeutic compositions and uses |
| 04/25/2013 | WO2013057499A1 Novel peptides |
| 04/25/2013 | WO2013057312A1 Agents and methods for the expression and secretion of peptides and proteins |
| 04/25/2013 | WO2013057219A1 Method for improving the stability of purified factor viii after reconstitution |
| 04/25/2013 | WO2013057141A2 Alpha-amylase variants and polynucleotides encoding same |
| 04/25/2013 | WO2013057078A1 Separation method for fucosylated antibodies |
| 04/25/2013 | WO2013056716A1 Pd-l1 based immunotherapy |
| 04/25/2013 | WO2013056664A1 Method and uses for bombyx mori silk fibroin heavy chain gene mutation sequence and mutant |
| 04/25/2013 | WO2013056377A1 Antigens derived from citrullinated 14-3-3 and uses thereof in the diagnosis of rheumatoid arthritis |
| 04/25/2013 | WO2013056372A1 Peptide compounds derived from melanotransferrin and uses thereof |
| 04/25/2013 | WO2013056309A1 Novel plant defensins and use in the treatment of proliferative diseases |
| 04/25/2013 | WO2013034666A3 Novel pheromonal receptor of spodoptera littoralis (lepidoptera, noctuidae) and identification of natural ligand of said receptor and uses thereof |
| 04/25/2013 | WO2013033456A3 Microbial nanowires and methods of making and using |
| 04/25/2013 | WO2013025945A3 Variant sucrose transporter polypeptides that enable faster sucrose utilization in bacteria |
| 04/25/2013 | WO2013019604A3 Protein production method |
| 04/25/2013 | WO2013017954A3 Tetrameric streptavidin mutein with reversible biotin binding capability |
| 04/25/2013 | WO2013012824A3 Trichoplusia ni piggybac transposases with reduced integration activity |
| 04/25/2013 | WO2012177444A3 Glucagon/glp-1 receptor co-agonists |
| 04/25/2013 | WO2012148832A8 Method for removing unmodified hemoglobin from cross-linked hemoglobin solutions including polymeric hemoglobin with high temperatures short time heat treatment apparatus |
| 04/25/2013 | WO2012021512A8 Erythrocyte-binding therapeutics |
| 04/25/2013 | WO2011120993A9 Polypeptides having transgalactosylating activity |
| 04/25/2013 | US20130104259 Axmi-115, axmi-113, axmi-005, axmi-163 and axmi-184: insecticidal proteins and methods for their use |
| 04/25/2013 | US20130104256 Isolated eIF-5A and Polynucleotides Encoding Same |
| 04/25/2013 | US20130102766 Method and compositions for monitoring dna binding molecules in living cells |
| 04/25/2013 | US20130102757 Methods for selective targeting |
| 04/25/2013 | US20130102657 Anti-angiogenic compositions and methods of use |
| 04/25/2013 | US20130102544 Disease-Associated Proteins |
| 04/25/2013 | US20130102533 Albumin fusion proteins |
| 04/25/2013 | US20130102530 Protection, Restoration and Enhancement of Erythropoietin-Responsive Cells, Tissues and Organs |
| 04/25/2013 | US20130102529 Iron (iii) caseinsuccinylate and method for the preparation thereof |
| 04/25/2013 | US20130102521 Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin |
| 04/25/2013 | US20130102495 Sperm-Specific Cation Channel, Catsper1 and Uses Therefor |
| 04/25/2013 | US20130102057 Vmp-like sequences of pathogenic borrelia species and strains |
| 04/25/2013 | US20130101664 Muc1 ligand traps for use in treating cancers |
| 04/25/2013 | US20130101628 Novel vegf mimetic peptide-based scaffolds for therapeutic angiogenesis and methods for their use |
| 04/25/2013 | US20130101626 Mucin antigen vaccine |
| 04/25/2013 | US20130101620 Recombinant varicella-zoster virus |
| 04/25/2013 | US20130101612 Vaccine for enveloped viruses |
| 04/25/2013 | US20130101605 Modulators and modulation of the interaction between rgm and neogenin |
| 04/25/2013 | US20130101603 Bmp-alk3 antagonists and uses for promoting bone growth |
| 04/25/2013 | US20130101588 Novel glycosylated peptide target in neoplastic cells |
| 04/25/2013 | US20130101585 Method of inhibiting osteoclast activity |